c.inglethorpe
TL3 Regular · Zürich, CH
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 18 January 2025 · last posted 1d · groups: pharmacists
119 posts, newest first. Showing up to 150.
-
[2026 update] Second opinions: how to seek one without burning the first Replied, post #3 · Clinical › Prescriber conversations · 26 Jul 2026 · 29 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #24 · Compounds › Oral incretins · 25 Jul 2026 · 0 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Seven-day rolling means and why weekly readings mislead Replied, post #80 · Outcomes › Progress reports · 22 Jul 2026 · 1 like Reporting rather than recommending, on seven-day rolling. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Publication patterns in the BPC-157 literature, examined Replied, post #41 · Compounds › Repair & healing peptides · 21 Jul 2026 · 6 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. That matches what I was…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #91 · Evidence › Journal club · 20 Jul 2026 · 1 like Answering the question post #88 raises rather than the one it answers. The reason SUSTAIN 6 keeps being re-asked is that the answer is conditional and people quote it…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #49 · Practice › Administration · 18 Jul 2026 · 0 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.…
-
Pages past their review date, listed — does this still hold? Replied, post #54 · Meta › Wiki maintenance · 15 Jul 2026 · 17 likes This follows post #51 rather than contradicting it. Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #31 · Compounds › Repair & healing peptides · 14 Jul 2026 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #100 · Compounds › Semaglutide · 13 Jul 2026 · 33 likes The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range across a studied population, and individual clearance varies enough that a person's own…
-
Journal club: what we got wrong in an earlier session Replied, post #69 · Evidence › Journal club · 10 Jul 2026 · 22 likes Post #68 answers the question as asked. The question underneath it is different. The baseline characteristics table is the single most useful page for the questions…
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #16 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 16 likes Coming back to post #12, because the follow-up matters more than the original answer. Mobile-phase preparation is a genuine source of between-laboratory variation. Acid…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #39 · Research Methods › Statistics · 7 Jul 2026 · 0 likes I read post #38 twice before replying, because I had assumed the opposite. The version of Absence of evidence that I was taught turned out to be a teaching…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #35 · Evidence › Trials · 4 Jul 2026 · 8 likes Primary endpoint hierarchies has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
How to ask a question when you cannot say why you are asking it Replied, post #29 · Start Here › How to Ask · 3 Jul 2026 · 23 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Alcohol: what is documented and what is folklore Replied, post #86 · Practice › Interactions · 1 Jul 2026 · 17 likes Post #83 put the caveat in the right place and I want to underline it. Alcohol came up in a thread eighteen months ago and was answered well. I cannot find it, which is…
-
A structured critique template this community uses — a second dataset Replied, post #24 · Evidence › Study critique · 30 Jun 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Insurance and replacement policies, compared Replied, post #47 · Sourcing › Logistics · 27 Jun 2026 · 0 likes The practical version of insurance and replacement policies is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #40 · Access › Insurance & coverage · 26 Jun 2026 · 3 likes The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #98 · Evidence › Journal club · 26 Jun 2026 · 25 likes Nothing to add, except that this is the answer I would give if asked.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #100 · Outcomes › Body composition · 22 Jun 2026 · 29 likes This follows post #99 rather than contradicting it. What I would tell a new member reading about Lean mass preservation for the first time: the confident posts are not…
-
Request: tag synonyms surfaced in search Replied, post #4 · Meta › Feature requests · 21 Jun 2026 · 28 likes Fair. Then under the name, at a smaller size, permanently. Happy to be the one who is wrong here if it settles the question.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #29 · Sourcing › Independent verification · 20 Jun 2026 · 5 likes Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies are explained by handling or method and asking costs a day. The short…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #3 · Compounds › Retatrutide · 15 Jun 2026 · 17 likes Coming back to the opening post, because the follow-up matters more than the original answer. I would keep TRIUMPH and the decision it usually gets used for separate in…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #9 · Outcomes › Body composition · 7 Jun 2026 · 5 likes I would keep ultrasound and skinfolds and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
A certificate whose chromatogram axes do not match its stated method — one year on Started this topic · Sourcing › Red flags · 2 Jun 2026 · 32 likes A certificate whose chromatogram axes do not match its stated method — one year on Writing it up because I had to work it out twice and would rather nobody else did.…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #8 · Practice › Storage & stability · 1 Jun 2026 · 9 likes Post #6 and I disagree about the size of the effect, not about the direction. I keep a log for reconstituted specifically because my memory of it turned out to be…
-
The best-written scientific paper you have read Replied, post #63 · Lounge › Off topic · 24 May 2026 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #28 · Compounds › Repair & healing peptides · 19 May 2026 · 17 likes Answering the question post #24 raises rather than the one it answers. The absence of adequately powered published randomised human trials is the central fact about…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #63 · Clinical › Bloodwork · 10 May 2026 · 0 likes The confident answers on Thyroid function tests during substantial and the well-sourced answers are not the same answers, which is the most useful thing I have learned…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #13 · Evidence › Study critique · 23 Apr 2026 · 3 likes Post #11 is right about the mechanism and I think understates the practical bit. I have been on both sides of the Measurement error argument in this category within…
-
Follow-up: Sleep quality changes during weight loss Replied, post #8 · Wellbeing › Sleep · 21 Apr 2026 · 0 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #112 · Pharmacology › Pharmacokinetics · 20 Apr 2026 · 24 likes Careful with the language on Washout. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Prescription portability between countries Replied, post #4 · Access › International · 8 Apr 2026 · 4 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
Spike-and-recover accuracy for a peptide assay Replied, post #26 · Analytics › Method validation · 7 Apr 2026 · 31 likes I read post #24 twice before replying, because I had assumed the opposite. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #30 · Evidence › Trials · 3 Apr 2026 · 10 likes Coming back to post #26, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
-
How to ask about something you suspect is a bad idea Replied, post #72 · Start Here › How to Ask · 2 Apr 2026 · 0 likes Worth separating two things that post #68 runs together. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #8 · Data & Tools › Calculators · 1 Apr 2026 · 5 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. Not the answer, but possibly…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #21 · Practice › Administration · 30 Mar 2026 · 5 likes Post #18 is the version of this I will quote in future. One addition. Completing a dose is one of those subjects where the general answer and the answer for a specific…
-
Citation sweep results: how many references did not say what was claimed Replied, post #69 · Meta › Wiki maintenance · 30 Mar 2026 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Second pass at: Identical chromatograms across two different lots Replied, post #90 · Sourcing › Red flags · 24 Mar 2026 · 7 likes Practical note on Identical chromatograms: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
-
Which fields on a certificate actually matter, ranked Replied, post #22 · Analytics › COA interpretation · 17 Mar 2026 · 1 like Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Managing an unplanned gap in supply Replied, post #59 · Access › Shortages · 13 Mar 2026 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. I would hold that lightly until someone with a larger…
-
Recording a dissent on a document rather than suppressing it Replied, post #7 · Documentation › Doc review · 9 Mar 2026 · 1 like Where I part company with post #5, and it is a narrow parting. A definition problem is doing most of the work in this recording a dissent discussion. Once the term is…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #3 · Evidence › Trials · 6 Mar 2026 · 0 likes Post #2 is the version of this I will quote in future. One addition. Subgroup analyses looks different depending on whether you are reading the primary literature or…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #2 · Devices › Syringes & needles · 23 Feb 2026 · 0 likes Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #2 · Analytics › Mass spectrometry · 11 Feb 2026 · 2 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error. I would…
-
Waist circumference technique and its repeatability Replied, post #49 · Outcomes › Progress reports · 9 Feb 2026 · 32 likes I read post #45 twice before replying, because I had assumed the opposite. What I can speak to on waist circumference technique is narrow, so I will keep it narrow…
-
A plateau that disappeared when I changed how I measured Replied, post #13 · Outcomes › Progress reports · 4 Feb 2026 · 0 likes Two claims get bundled together under plateau and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Research-use-only labelling: what it means and what it does not Replied, post #83 · Sourcing › Regulatory · 5 Jan 2026 · 7 likes Understood, and I withdraw the assumption I opened with.
-
Oral semaglutide bioavailability and its variability between people Replied, post #25 · Compounds › Oral incretins · 2 Jan 2026 · 8 likes Post #22 answers the question as asked. The question underneath it is different. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #33 · Sourcing › Red flags · 31 Dec 2025 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #5 · Compounds › Secretagogues & GH axis · 27 Dec 2025 · 25 likes Post #2 answers the question as asked. The question underneath it is different. The most useful thing anyone has posted about Evidence quality in this category was a…
-
Pregnancy and pregnancy planning: contraindication and washout Started this topic · Clinical › Special populations · 24 Dec 2025 · 4 likes Posting this under the heading it deserves: Pregnancy and pregnancy planning: contraindication and washout Everything below is what sits behind that. Pregnancy and…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #43 · Access › Pricing · 22 Dec 2025 · 0 likes Everything in post #39 holds. The case it does not cover is the one I have. The documentation on Price changes is better than this thread and I say that as someone who…
-
Guidelines revision: what changed and why — one year on Replied, post #48 · Meta › Announcements · 19 Dec 2025 · 3 likes Answering the question post #45 raises rather than the one it answers. Speaking only to Guidelines revision as I have actually seen it, rather than as it is usually…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #66 · Compounds › Semaglutide · 10 Dec 2025 · 9 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Tracking a preprint to publication: a worked example Replied, post #48 · Evidence › Preprints · 4 Dec 2025 · 15 likes Taking post #47 at face value and following it one step further. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
A history of disordered eating: proceeding carefully Replied, post #19 · Wellbeing › Mental health · 3 Dec 2025 · 6 likes Adding the measurement that post #18 says would settle it. Summarising the history of disordered eating thread so far, since it is long and the answer is buried: the…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #13 · Safety › Contraindications · 28 Nov 2025 · 30 likes Post #11 answers the question as asked. The question underneath it is different. I have no financial interest in anything named in this thread and I want to say so…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #73 · Practice › Reconstitution · 26 Nov 2025 · 7 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #54 · Compounds › Other compounds · 24 Nov 2025 · 0 likes My understanding of Sequence verification is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
How to ask about something you suspect is a bad idea Replied, post #25 · Start Here › How to Ask · 15 Nov 2025 · 0 likes Coming back to post #23, because the follow-up matters more than the original answer. It is fine to say you cannot explain why you are asking. Nobody will press, and…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #16 · Compounds › Retatrutide · 14 Nov 2025 · 27 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Thyroid function tests during substantial weight change Replied, post #127 · Clinical › Bloodwork · 9 Nov 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #30 · Start Here › How to Ask · 7 Nov 2025 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Context that matters: compound, how long in, current dose,…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #7 · Start Here › Welcome · 4 Nov 2025 · 1 like Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
The headache that turns out to be dehydration Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 18 Oct 2025 · 0 likes Post #25 and I disagree about the size of the effect, not about the direction. Symptoms attributed to electrolytes here are non-specific and overlap with dehydration,…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #33 · Analytics › Method validation · 18 Oct 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Publishing an inconvenient result: a case study — the long version Replied, post #10 · Sourcing › Independent verification · 15 Oct 2025 · 1 like I disagree with the framing of Publishing an inconvenient result above, and I think it is a substantive disagreement rather than a terminological one. Setting out why,…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #59 · Practice › Storage & stability · 29 Sep 2025 · 3 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
-
What a purity-only report leaves out Replied, post #28 · Sourcing › Independent verification · 28 Sep 2025 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. I would want the raw data before agreeing with my…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #8 · marked as the solution · Compounds › Tirzepatide · 14 Sep 2025 · 24 likes Building on post #7 rather than restating it. I would rather this thread reach "we do not know" about Reading SURMOUNT-1 without the press than reach a confident answer…
-
Documenting an adverse event properly Replied, post #8 · Safety › Adverse events · 14 Sep 2025 · 11 likes That is consistent with mine, for whatever one more account is worth.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #31 · Compounds › Other compounds · 30 Aug 2025 · 13 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #31 · Evidence › Journal club · 19 Aug 2025 · 19 likes Post #27 describes the usual case. This is about the unusual one. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
Revisiting: Filing a first vendor report: a worked example Replied, post #3 · Sourcing › Vendor reports · 19 Aug 2025 · 27 likes Post #2 is the version of this I will quote in future. One addition. The service matters to the interpretation. A documentation review and a chromatographic assay…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #25 · Access › Pricing · 10 Aug 2025 · 32 likes Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious.
-
What this community means by "a source", in practical terms Replied, post #64 · Start Here › Welcome · 9 Aug 2025 · 12 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #140 · Access › Insurance & coverage · 16 Jun 2025 · 7 likes Two people in this thread mean different things by appeal and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
Risk-of-bias tools and the judgement they conceal Replied, post #5 · Evidence › Meta-analyses · 15 Jun 2025 · 0 likes The most useful thing a review can publish is the excluded-studies table with reasons. It is where the judgement is and it is almost always in a supplement. Posted with…
-
A well-designed study with a badly written abstract Replied, post #121 · Evidence › Study critique · 1 Jun 2025 · 0 likes If someone has run well-designed study properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #17 · Pharmacology › Pharmacokinetics · 27 May 2025 · 9 likes Adding a reference point for Clearance pathways. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #9 · Compounds › Secretagogues & GH axis · 24 May 2025 · 0 likes Post #8 is right about the mechanism and I think understates the practical bit. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #3 · Practice › Reconstitution · 22 May 2025 · 0 likes If someone has run decimal-point error properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #125 · Sourcing › Independent verification · 20 May 2025 · 14 likes The arithmetic in post #122 is right; the assumption feeding it is the part to check. Janoshik has a well-known answer and a correct answer, and the interesting work is…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #100 · Access › Pricing · 14 May 2025 · 26 likes Post #96 put the caveat in the right place and I want to underline it. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates.…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #6 · Analytics › Method validation · 11 May 2025 · 1 like The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. Not the answer, but possibly the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #142 · Sourcing › Regulatory · 2 May 2025 · 4 likes Research-use-only labelling is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #73 · Compounds › Tirzepatide · 30 Apr 2025 · 7 likes Where I have landed on tirzepatide in type 2 diabetes, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Scheduled maintenance and what will be unavailable Replied, post #125 · Meta › Announcements · 27 Apr 2025 · 30 likes This follows post #122 rather than contradicting it. The claim about scheduled maintenance upthread is stronger than its source supports. I have read the source. The…
-
Follow-up: What other technical communities get right that we do not Replied, post #55 · Lounge › Off topic · 1 Apr 2025 · 0 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
Ipamorelin selectivity claims and where they came from Replied, post #22 · Compounds › Secretagogues & GH axis · 21 Mar 2025 · 23 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #37 · Clinical › Comorbidities · 19 Mar 2025 · 21 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. That is my reading.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #109 · Access › International · 19 Mar 2025 · 5 likes Understood. Thank you for being specific about the limits of it.
-
Charge states for a 4 kDa peptide, worked through Replied, post #124 · Analytics › Mass spectrometry · 16 Mar 2025 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Validating a method you did not develop — does this still hold? Replied, post #48 · Analytics › Method validation · 26 Feb 2025 · 0 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Two sentences on Validating a method and then I will stop, because…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #25 · Practice › Reconstitution · 3 Feb 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #11 · Wellbeing › Mental health · 30 Jan 2025 · 0 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #49 · Compounds › Secretagogues & GH axis · 25 Jan 2025 · 16 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #111 · Compounds › Tirzepatide · 22 Jan 2025 · 9 likes Post #107 put the caveat in the right place and I want to underline it. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #14 · Compounds › Other compounds · 19 Jan 2025 · 10 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Follow-up: Individual participant data versus aggregate data Replied, post #91 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes When trials differ in population, duration and comparator, the pooled estimate answers a question no individual trial asked. That is worth saying before the number is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #76 · Evidence › Journal club · 30 Dec 2024 · 24 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #52 · Compounds › Semaglutide · 28 Dec 2024 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #14 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled 5 mg of peptide as an acetate salt and one labelled 5 mg as trifluoroacetate do…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #95 · Compounds › Tirzepatide · 18 Dec 2024 · 21 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Here for the analytics and not much else — one year on Replied, post #9 · Lounge › Introductions · 17 Dec 2024 · 4 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
-
Body image changing more slowly than the body Replied, post #4 · Wellbeing › Mental health · 10 Dec 2024 · 0 likes I have been on both sides of the body image argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #3 · Access › Insurance & coverage · 23 Oct 2024 · 2 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. That is a description of practice, not a recommendation of it.
-
Promotion criteria, and the one that stops most nominations Replied, post #87 · Documentation › Doc review · 16 Oct 2024 · 22 likes The most useful reply I ever got about promotion criteria was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #70 · Practice › Administration · 1 Oct 2024 · 0 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. Practical experience of site rotation scheme, offered as one case with the…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #48 · Analytics › Mass spectrometry · 19 Aug 2024 · 23 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Circumference measurements as a poor man's composition estimate Replied, post #31 · Outcomes › Body composition · 31 Jul 2024 · 11 likes Comparing a body composition result against a population reference is a different exercise from tracking your own change, and the second is what most people want. I…
-
Guidelines revision: what changed and why Replied, post #84 · Meta › Announcements · 27 Jul 2024 · 0 likes The arithmetic in post #83 is right; the assumption feeding it is the part to check. Taking guidelines revision seriously for a moment rather than deflecting: the…
-
Guidelines revision: what changed and why Replied, post #67 · Meta › Announcements · 27 Jul 2024 · 0 likes Everything in post #65 holds. The case it does not cover is the one I have. Reading the changed pages: the diff is smaller than the announcement implies, which is…
-
How to ask for a dose change without antagonising anyone Replied, post #8 · marked as the solution · Clinical › Prescriber conversations · 24 Jul 2024 · 22 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #62 · Practice › Dosing & titration · 8 Jul 2024 · 1 like Coming back to post #60, because the follow-up matters more than the original answer. If symptoms reset at each step, that is the expected pattern rather than a sign…
-
The mass-error checker and its intended scope Replied, post #46 · Data & Tools › Calculators · 12 Jun 2024 · 27 likes Two claims get bundled together under mass-error checker and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
The mass-error checker and its intended scope Replied, post #11 · Data & Tools › Calculators · 25 May 2024 · 0 likes Before the thread moves on from mass-error checker — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…